MARCH - APRIL 2022LIFE SCIENCES REVIEW4CONTENTS2522Marc Lacey,Global Pandemic Head, SeqirusBrent Stutz,SVP of Commercial Technologies,Cardinal Health,Cardinal Health [NYSE:CAH]Grappling with Unpredictability: The Art and Science of Pandemic PreparednessFUSING PHARMA TECHNOLOGY AND HEALTHCARECXO INSIGHTS12COVER STORYQ²SOLUTIONSA LEADING GLOBAL CLINICAL TRIAL LABORATORYSERVICES ORGANIZATIONBRIAN O'DWYER, CEO33Clinical Trial Technology: Drive Adoption with PeopleDawn Niccum,Director,Quality Assurance,inSeptionGroup
< Page 3 | Page 5 >